Elidel
Links shared publicly online about this topic
Novartis Sells Global Rights to Elidel, A Medicine to Treat Atopic Dermatitis - Drugs.com MedNews
drugs.com — “Novartis to receive USD 420 million cash payment from Meda Novartis to focus commercialization efforts on new launch portfolio Basel, April 7, 2011 - Novartis a” View full resource at drugs.com
Most Recently Shared on April 7, 2011 at 12:07 pm By:
Drugs and Devices OW OW Health
Novartis Sells Global Rights to Elidel, A Medicine to Treat Atopic Dermatitis: * Novartis to receive USD 4... http://bit.ly/fZAHZR #drug
Novartis Continues Portfolio Revamp With $420M Elidel Sale - WSJ.com
online.wsj.com — “Novartis Continues Portfolio Revamp With $420M Elidel Sale - WSJ.com” View full resource at online.wsj.com
Most Recently Shared on April 7, 2011 at 12:10 pm By:
Shalona Anuj, PhD Doctor, Organic Advocate, Skin and Beauty, and PhD
Novartis Continues Portfolio Revamp With $420M Elidel Sale http://bit.ly/hIsqRc
Eczema drugs may need tougher warning - Skin and beauty- msnbc.com
msnbc.msn.com — “Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday.” View full resource at msnbc.msn.com
Most Recently Shared on March 18, 2010 at 5:41 pm By:
msnbc.com - Health Health News
Eczema drugs may need tougher warning http://bit.ly/9VK2og
May need wider eczema caution for kids: FDA | Reuters
reuters.com — “WASHINGTON (Reuters) - Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration” View full resource at reuters.com
Most Recently Shared on March 19, 2010 at 12:00 am By:
Hisham Rana, MD Doctor and Physician
News: Novartis & Astellas eczema drugs may need wider warnings due to reports of cancer and infection in kids. http://bit.ly/da9b0c #pharma
Eczema drugs may need tougher warning - Skin and beauty- msnbc.com
msnbc.msn.com — “Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday.” View full resource at msnbc.msn.com
Most Recently Shared on March 18, 2010 at 3:54 pm By:
Eczema drugs may need tougher warning: Novartis AG and Astellas Pharma eczema drugs may need their warnin... http://bit.ly/b99hdi #children
FDA staff recommends stronger label for 2 eczema drugs - Related Stories - AAP SmartBrief
smartbrief.com — “FDA staff said eczema medicines Elidel from Novartis and Protopic from Astellas Pharma might need to carry a warning label that mentions cases of cancer and infection in children. The staff reported the information ahead of a panel review on the safety of drugs used by children. <a href='/servlet/aa” View full resource at smartbrief.com
Most Recently Shared on March 20, 2010 at 1:00 am By:
Clara Song Doctor, Pediatrician, and Physician
FDA staff recommends stronger label for 2 eczema drugs http://sbne.ws/r/48sz
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Shalona Anuj, PhD
Organic Beauty Care ~ Environmental Education ~ Eco Gift Ideas ~ Buy Organic ~ Love Yourself ~ Love Your Planet
-
msnbc.com - Health
Health, diet and nutrition news from msnbc.com
Advertisement
